Søgning på udtrykket 'influenza' giver 45 resultater


Dokumenter [1] Sider [1] Kalender [3] Nyt fra tidsskrifterne [+20] Aktuelle smitsomme sygdomme [+20]

Dokumenter [1]

Version 8 (21.11.22) Udarbejdet af Dansk Selskab for Infektionsmedicin i samarbejde med Dansk Selskab for Klinisk Mikrobiologi, Dansk Hæmatologisk Selskab, Dansk Pædiatrisk Selskab, Dansk Selskab for Almen Medicin, Dansk Lungemedicinsk Selskab, Dansk Selskab for Obstetrik og Gynækologi, Dansk Transplantationsselskab, Dansk Selskab for Klinisk Onkologi & Fagligt Selskab for Hygiejnesygeplejersker

Sider [1]

…nti-TNF-alfa (2011), Tjekliste ved screening før behandling med anti-TNF-alpha, Indvandrermedicin: Chalotte Stecher (tovholder), Hanne Nødgaard Christensen, Christian Wejse, Jane Agergaard, Morten Sodemann og Marie Nørredam Influenza: Jens Lundgren (tovholder), Thomas Benfield, Jan Gerstoft, Isik Johansen, Gitte Kronborg, Henrik Nielsen, Lene Surland Knudsen, Merete Storgaard og Ole Kirk Influenza, Inspektorordningen i Sundhedsstyrelsen: Hanne Arildsen, Th…


Kalender [3]

24. januar 2019, Aarhus Universitetshospital

Nyt fra tidsskrifterne [+20]

Der er mere end 20 resultater, måske du vil se flere resultater her?
Journal of Infectious Diseases
17.05.2024
Abstract . Background . Several influenza vaccine candidates aim to elicit antibodies against the conserved hemagglutinin stalk domain. Understanding the protective mechanism of these antibodies, which mediate broad neutralization and Fc-mediated functions, following seasonal vaccination is critical.Methods . Plasma samples were obtained from a subset of pregnant women living with or without HIV-1 enrolled in a randomised trial (138 trivalent inactivated vaccine [TIV] and 145 placebo recipients). Twenty-thr…
Emerg Microbes Infect
16.05.2024
Volume 13, Issue 1, December 2024 .
Journal of Medical Virology
16.05.2024
Journal of Medical Virology, Volume 96, Issue 5, May 2024.
FEMS Microbiology Reviews
12.05.2024
Abstract . Avian influenza viruses evolve antigenically to evade host immunity. Two influenza A virus surface glycoproteins, the haemagglutinin and neuraminidase, are the major targets of host immunity and undergo antigenic drift in response to host pre-existing humoral and cellular immune responses. Specific sites have been identified as important epitopes in prominent subtypes such as H5 and H7 which are of animal and public health significance due to their panzootic and pandemic potential. The haemagglut…
Journal of Medical Virology
11.05.2024
Journal of Medical Virology, Volume 96, Issue 5, May 2024.
Journal of Infectious Diseases
11.05.2024
Abstract . Background . Influenza virus remains a threat to human health, but gaps remain in our knowledge of the humoral correlates of protection against influenza virus A/H3N2, limiting our ability to generate effective, broadly protective vaccines. The role of antibodies against the hemagglutinin (HA) stalk, a highly conserved but immunologically sub-dominant region, has not been established for influenza virus A/H3N2.Methods . Household transmission studies were conducted in Managua, Nicaragua across th…
Science Advances
11.05.2024
Science Advances, Volume 10, Issue 19, May 2024.
PLoS One Infectious Diseases
11.05.2024
by Oiythip Yasopa, Nontiya Homkham, Pornthip Chompook . This study was aimed to explore the association between potential factors including public health and social measures and the number of influenza patients in Thailand between 2014–2021. Secondary data from relevant agencies were collected. Generalized Estimating Equation (GEE) and regression coefficient (β) were performed at a significance level of 0.05. We found factors associated with number of influenza patients during the time prior to COVID-19…
Clinical Infectious Diseases
7.05.2024
CLSIpharmacokineticspharmacodynamicssusceptibilityantimicrobial susceptibility testingamoxicillin clavulanate
New England Journal of Medicine
4.05.2024
New England Journal of Medicine, Ahead of Print.
BMC Infectious Diseases
3.05.2024
. Abstract. . Background. Hospital-acquired influenza (HAI) is under-recognized despite its high morbidity and poor health outcomes. The early detection of HAI is crucial for curbing its transmission in hospital settings. . . . Aim. This study aimed to investigate factors related to HAI, develop predictive models, and subsequently compare th…
Journal of Infectious Diseases
3.05.2024
Abstract . Studies have reported that prior-season influenza vaccination is associated with higher risk of clinical influenza infection among vaccinees. This effect might arise from incomplete consideration of within-season waning and recent infection. Using data from the US Flu Vaccine Effectiveness (VE) Network (2011-2012 to 2018-2019 seasons), we found that repeat vaccinees were vaccinated earlier in a season by one week. After accounting for waning VE, repeat vaccinees were still more likely to test pos…
Emerg Microbes Infect
30.04.2024
Volume 13, Issue 1, December 2024 .
BMC Infectious Diseases
24.04.2024
. Abstract. . Background. Influenza-like illness (ILI) imposes a significant burden on patients, employers and society. However, there is no analysis and prediction at the hospital level in Chongqing. We aimed to characterize the seasonality of ILI, examine age heterogeneity in visits, and predict ILI peaks and assess whether they affect hospital operations. . . . …
BMJ Open
23.04.2024
. Objective. The 2022 Australian winter was the first time that COVID-19, influenza and respiratory syncytial virus (RSV) were circulating in the population together, after two winters of physical distancing, quarantine and borders closed to international travellers. We developed a novel surveillance system to estimate the incidence of COVID-19, influenza and RSV in three regions of Queensland, Australia. . Design. We implemented a longitudinal testing-based sentinel surveillance programme. Participants we…
Journal of Medical Virology
19.04.2024
Journal of Medical Virology, Volume 96, Issue 4, April 2024.
International Journal of Infectious Diseases
17.04.2024
The emergence of the COVID-19 pandemic, caused by SARS-CoV-2, has undeniably reshaped life on a global scale. As infection rates and fatalities surged to historic proportions, initial strategies to combat the crisis revolved around non-pharmaceutical interventions (NPIs) such as the use of facemasks, physical distancing, travel bans, and lockdowns, considering the absence of available vaccines or targeted therapeutics. Characterized by a spectrum of actions spanning individual precautions to broader societa…

Aktuelle smitsomme sygdomme [+20]

Der er mere end 20 resultater, måske du vil se flere resultater her?
Medscape Infectious Diseases
18.05.2024
The U.S. Centers for Disease Control and Prevention (CDC) on Tuesday released data on influenza A found in wastewater in a public dashboard that could assist in tracking the. . Reuters Health Information
Eurosurveillance latest updates
26.04.2024
A severe outbreak of influenza A(H1N1pdm09) infection in seven children (median age: 52 months) occurred between December 2023 and January 2024 in Tuscany, Italy. Clinical presentation ranged from milder encephalopathy to acute necrotizing encephalopathy (ANE) with coma and multiorgan failure; one child died. This report raises awareness for clinicians to identify and treat early acute encephalopathy caused by H1N1 influenza and serves as a reminder of severe presentations of influenza in young children and…
Eurosurveillance latest updates
12.04.2024
…ropean Mortality Monitoring Network (EuroMOMO) has observed excess mortality in Europe. During weeks 48 2023–6 2024, preliminary results show a substantially increased rate of 95.3 (95% CI:  91.7–98.9) excess all-cause deaths per 100,000 person-years for all ages. This excess mortality is seen in adults aged 45 years and older, and coincides with widespread presence of COVID-19, influenza and respiratory syncytial virus (RSV) observed in many European countries during the 2023/24 winter season. .
Morbidity and Mortality Weekly Report (MMWR)
29.02.2024
This report describes estimated vaccine effectiveness for laboratory-confirmed flu in California.
Morbidity and Mortality Weekly Report (MMWR)
29.02.2024
This report describes estimates of 2023-24 influenza vaccine effectiveness among different age groups.
Eurosurveillance latest updates
23.02.2024
. Background. Waning immunity from seasonal influenza vaccination can cause suboptimal protection during peak influenza activity. However, vaccine effectiveness studies assessing waning immunity using vaccinated and unvaccinated individuals are subject to biases. . . Aim. We examined the association between time since vaccination and laboratory-confirmed influenza to assess the change in influenza vaccine protection over time. . . Methods. Using linked laboratory and health administrative databases in…
Eurosurveillance latest updates
23.02.2024
Influenza A viruses circulated in Europe from September 2023 to January 2024, with influenza A(H1N1)pdm09 predominance. We provide interim 2023/24 influenza vaccine effectiveness (IVE) estimates from two European studies, covering 10 countries across primary care (EU-PC) and hospital (EU-H) settings. Interim IVE was higher against A(H1N1)pdm09 than A(H3N2): EU-PC influenza A(H1N1)pdm09 IVE was 53% (95% CI: 41 to 63) and 30% (95% CI: −3 to 54) against influenza A(H3N2). For EU-H, these were…
Eurosurveillance latest updates
16.02.2024
The Canadian Sentinel Practitioner Surveillance Network reports mid-season 2023/24 influenza vaccine effectiveness (VE) of 63% (95% CI: 51–72) against influenza A(H1N1)pdm09, lower for clade 5a.2a.1 (56%; 95% CI: 33–71) than clade 5a.2a (67%; 95% CI: 48–80), and lowest against influenza A(H3N2) (40%; 95% CI: 5–61). The Omicron XBB.1.5 vaccine protected comparably well, with VE of 47% (95% CI: 21–65) against medically attended COVID-19, higher among people reporting a prior confirmed SARS…
ECDC COVID-19 updates
15.02.2024
AURORAE provides laboratory support for surveillance, preparedness and response to COVID-19 and influenza and strengthens the capacity for genomic epidemiology and public health bioinformatics through interdisciplinary training, which is crucial for response during a pandemic or unexpected major public health events.
ECDC COVID-19 updates
6.02.2024
This core protocol for ECDC studies of VE against hospitalisation with SARI laboratory-confirmed with SARS-CoV-2 or with influenza, version 3.0, represents an update to the main elements for a multi-country hospital-based study of COVID-19 vaccine effectiveness in patients hospitalised with SARI, initially published as version 1.0 [5], updated to version 2.0 [6].
Eurosurveillance latest updates
26.01.2024
. Background. Influenza was almost absent for 2 years following the implementation of strict public health measures to prevent the spread of SARS-CoV-2. The consequence of this on infections in different age groups is not yet known. . . Aim. To describe the age groups infected with the influenza virus in 2021/22, the first post-pandemic influenza season in Denmark, compared with the previous six seasons, and subtypes circulating therein. . . Methods. Infection and hospitalisation incidences per season…
Eurosurveillance latest updates
19.01.2024
Under International Health Regulations from 2005, a human infection caused by a novel influenza A virus variant is considered an event that has potential for high public health impact and is immediately notifiable to the World Health Organisation. We here describe the clinical, epidemiological and virological features of a confirmed human case of swine influenza A(H1N2)v in England detected through community respiratory virus surveillance. Swabbing and contact tracing helped refine public health risk assess…
Eurosurveillance latest updates
12.01.2024
Timely and precise influenza vaccine effectiveness (VE) estimates are needed to guide public health messaging and impact vaccine uptake immediately. Using routinely collected laboratory, vaccination and health administrative data from Alberta, Canada, we estimated influenza VE against infection for the 2023/24 season on a near real-time basis, to late December, at 61% (95% CI: 58–64) against influenza A(H1N1), 49% (95% CI: 28–63) against influenza A(H3N2) and 75% (95% CI: 58–85) against influenz…
Morbidity and Mortality Weekly Report (MMWR)
21.12.2023
This report describes influenza, updated COVID-19, and respiratory syncytial virus vaccination coverage among adults.
Morbidity and Mortality Weekly Report (MMWR)
21.12.2023
This report describes respiratory syncytial virus, influenza, and COVID-19 vaccination coverage among nursing home residents.
Eurosurveillance latest updates
8.12.2023
. Background. Influenza vaccination for children aged 6 months to 6 years is included in the national vaccination programme in Finland. Although all vaccines in the programme are free of charge, national coverage of influenza vaccination among children under 3 years and 3–6 years during 2020/21 was 43% and 35% respectively, with regional differences. . . Aim. To assess factors underlying parental vaccination intention in order to increase influenza vaccine uptake among children. . . Methods. We cond…
Morbidity and Mortality Weekly Report (MMWR)
1.12.2023
This report describes the percentage of adults who received a flu vaccine during the past 12 months.
Morbidity and Mortality Weekly Report (MMWR)
9.11.2023
This report describes declines in influenza vaccination coverage among health care personnel working in hospitals during the COVID-19 pandemic.
Morbidity and Mortality Weekly Report (MMWR)
9.11.2023
This report describes the percentage of health care personnel working in hospitals and nursing homes who received a flu vaccine and the percentage who received a COVID-19 vaccine.
Eurosurveillance latest updates
20.10.2023
We report cases of mammalian infection with highly pathogenic avian influenza (HPAI) virus A(H5N1) clade 2.3.4.4b in Northern Ireland. Two common gulls (Larus canus) and two red fox kits (Vulpes vulpes), were found dead in close vicinity. Comparison of viral whole genome sequences obtained from the animals identified a novel mammalian adaptation, PB2-M535I. Analysis of genetic sequences from other recent mammalian infections shows that this mutation has arisen on at least five occasions in three European co…

DSI på

Følg os på linkedin.com/company/dansk-selskab-for-infektionsmedicin

Nyhedsbrev

Skriv din email adresse og modtag nyheder om hjemmesiden.


© 2024 Dansk Selskab for Infektionsmedicin

CVR: 33634307

www.infmed.dk
Version: 2.12.4
PHP version: 8.0.30
Design: Christian Philip Fischer
Side indlæst på 0.938 s

Cookies og privatliv